JP2023524401A5 - - Google Patents
Info
- Publication number
- JP2023524401A5 JP2023524401A5 JP2022563990A JP2022563990A JP2023524401A5 JP 2023524401 A5 JP2023524401 A5 JP 2023524401A5 JP 2022563990 A JP2022563990 A JP 2022563990A JP 2022563990 A JP2022563990 A JP 2022563990A JP 2023524401 A5 JP2023524401 A5 JP 2023524401A5
- Authority
- JP
- Japan
- Prior art keywords
- capsid protein
- aav
- genetically modified
- amino acid
- mutated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025267976A JP2026062759A (ja) | 2020-05-01 | 2025-12-19 | 遺伝子治療の増強のためのアデノ随伴ウイルス(aav)の制御された修飾 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018573P | 2020-05-01 | 2020-05-01 | |
| US63/018,573 | 2020-05-01 | ||
| PCT/US2021/030489 WO2021222899A1 (en) | 2020-05-01 | 2021-05-03 | Controlled modification of adeno-associated virus (aav) for enhanced gene therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025267976A Division JP2026062759A (ja) | 2020-05-01 | 2025-12-19 | 遺伝子治療の増強のためのアデノ随伴ウイルス(aav)の制御された修飾 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524401A JP2023524401A (ja) | 2023-06-12 |
| JP2023524401A5 true JP2023524401A5 (cg-RX-API-DMAC7.html) | 2024-05-08 |
| JP7862320B2 JP7862320B2 (ja) | 2026-05-19 |
Family
ID=76392408
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563990A Active JP7862320B2 (ja) | 2020-05-01 | 2021-05-03 | 遺伝子治療の増強のためのアデノ随伴ウイルス(aav)の制御された修飾 |
| JP2025267976A Pending JP2026062759A (ja) | 2020-05-01 | 2025-12-19 | 遺伝子治療の増強のためのアデノ随伴ウイルス(aav)の制御された修飾 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025267976A Pending JP2026062759A (ja) | 2020-05-01 | 2025-12-19 | 遺伝子治療の増強のためのアデノ随伴ウイルス(aav)の制御された修飾 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230175013A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4143206A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7862320B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230005941A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115551878A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021264081A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3177573A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL297780A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222899A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116333058A (zh) * | 2023-02-14 | 2023-06-27 | 国家纳米科学中心 | 可定点修饰抗原的病毒样颗粒及其构建方法与应用 |
| WO2025188967A1 (en) | 2024-03-06 | 2025-09-12 | Trustees Of Boston College | Precise adeno-associated virus-protein conjugates and uses thereof |
| TW202609054A (zh) * | 2024-05-01 | 2026-03-01 | 日商Jcr製藥股份有限公司 | 經修飾之aav粒子、其製造方法、相關之醫藥及其製造方法 |
| WO2026037731A1 (en) | 2024-08-12 | 2026-02-19 | Coave Therapeutics | Squaramide-modified viral vectors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4480268B2 (ja) * | 1998-02-12 | 2010-06-16 | イミューン コンプレックス コーポレイション | 戦略的修飾されたb型肝炎コアタンパク質及びそれらの誘導体 |
| PL2657248T3 (pl) * | 2003-06-19 | 2017-09-29 | Genzyme Corporation | Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie |
| EP1828390B1 (en) * | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| EP2396343B1 (en) * | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| CN104592364B (zh) * | 2013-10-30 | 2018-05-01 | 北京大学 | 定点突变和定点修饰的腺相关病毒、其制备方法及应用 |
| JP6836999B2 (ja) * | 2015-03-24 | 2021-03-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | アデノ随伴ウイルス変異体及びその使用方法 |
| WO2019221992A1 (en) * | 2018-05-15 | 2019-11-21 | President And Fellows Of Harvard College | Viral vectors exhibiting improved gene delivery properties |
-
2021
- 2021-05-03 KR KR1020227042010A patent/KR20230005941A/ko active Pending
- 2021-05-03 EP EP21731860.9A patent/EP4143206A1/en active Pending
- 2021-05-03 US US17/922,425 patent/US20230175013A1/en active Pending
- 2021-05-03 WO PCT/US2021/030489 patent/WO2021222899A1/en not_active Ceased
- 2021-05-03 CA CA3177573A patent/CA3177573A1/en active Pending
- 2021-05-03 CN CN202180032267.7A patent/CN115551878A/zh active Pending
- 2021-05-03 JP JP2022563990A patent/JP7862320B2/ja active Active
- 2021-05-03 AU AU2021264081A patent/AU2021264081A1/en active Pending
- 2021-05-03 IL IL297780A patent/IL297780A/en unknown
-
2025
- 2025-12-19 JP JP2025267976A patent/JP2026062759A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101080628B1 (ko) | 효모에서 hpv 31 l1의 최적 발현 | |
| JP5616879B2 (ja) | 酵母におけるhpv58l1の最適化発現 | |
| Daemen et al. | Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7 | |
| JP7862320B2 (ja) | 遺伝子治療の増強のためのアデノ随伴ウイルス(aav)の制御された修飾 | |
| CA2172139A1 (en) | Endosomolytically active particles | |
| CN112041451A (zh) | 基于aav的基因和蛋白质递送模块化系统 | |
| CN106399350A (zh) | 一种猪圆环病毒ii型病毒样颗粒疫苗及其制备方法 | |
| WO2023051850A1 (zh) | 一类来源于新型冠状病毒s2蛋白hr区域的重组融合蛋白及其应用 | |
| US20070041999A1 (en) | Production of multivalent virus like particles | |
| CN106795518A (zh) | 人类乳头瘤病毒构建体 | |
| CN110893234A (zh) | 一种犬瘟热、犬细小病毒病、狂犬病三联亚单位疫苗 | |
| CN103333849B (zh) | 金黄色葡萄球菌突变株及其制备方法和应用 | |
| US20150202282A1 (en) | Pcv2 orf2 virus like particle with foreign amino acid insertion | |
| WO2024199469A1 (zh) | 具有稳定融合前构象的呼吸道合胞病毒f蛋白 | |
| CN107034226A (zh) | 一种可溶性重组蛋白及其表达纯化方法和用途 | |
| CN119095973A (zh) | 腺相关病毒的缀合 | |
| CN102643349B (zh) | 携带乙肝病毒抗原表位的重组嵌合蛋白及其制备 | |
| CN102643335B (zh) | 重组轮状病毒vp6载体蛋白及其制备 | |
| CN101775375B (zh) | 制备含eb病毒潜伏膜蛋白1,2基因的重组腺相关病毒及其应用 | |
| CN110669142A (zh) | 融合rgd的猪圆环病毒2型病毒样颗粒、突变型感染性克隆及其制备方法和应用 | |
| Xiao et al. | Enhanced expression of GCRV VP6 in CIK cells by relative sequence optimization | |
| Gedvilaite et al. | Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity | |
| CN114805599A (zh) | 一种基于ADDomer嵌合猪O型口蹄疫病毒抗原表位的VLPs及应用 | |
| EP4495247A1 (en) | Virus-like particle containing capsid proteins connected by linker | |
| US20250281594A1 (en) | Truncated recombinant l1 protein of human papillomavirus |